“Type I agents include cis-diamminedichloroplatinum (II), 4'-(9-acridinylamino)methanesulphon-m-anisidide, neocarzinostatin, nitrogen mustard, adriamycin , daunorubicin and mitomycin C--drugs whose biological activities are reduced in the presence of HA.”